Chiropractors in Jericho, VT Accepting Medicare
7 Chiropractors found. Showing 1 - 7
 Timothy Joseph Farrell, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 213e Vt Route 15, Jericho, VT 05465 Phone: 802-899-9991 Fax: 802-899-1772 |
 Jericho Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 397 Route 15, Jericho, VT 05465 Phone: 802-899-5400 Fax: 802-355-3009 |
 Mary Helen Kintner, D.C., R.N. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 397 Vermont Route 15, Jericho, VT 05465 Phone: 802-899-5400 Fax: 802-899-5497 |
Dr. Leah Marie Nyaletey, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 213 Vt 15, Jericho, VT 05465 Phone: 802-899-9991 |
Dr. Elizabeth Horne, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 213e Vt Route 15, Jericho, VT 05465 Phone: 802-899-9991 |
Farrell Chiropractic Center, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 213e Vt Route 15, Jericho, VT 05465 Phone: 802-899-9991 Fax: 802-899-1772 |
Kintner Chiropractic Center, Pc Chiropractor - Nutrition Medicare: Not Enrolled in Medicare Practice Location: 397 Vt Route 15, Jericho, VT 05465 Phone: 802-899-5400 |
News Archive
SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids
With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.
As Congress ponders spending cuts, health care industry, advocates urge Medicare be spared
Congress returns today and begins efforts to negotiate a budget deal that would avert the "fiscal cliff" of automatic spending cuts and tax increases, which are slated to take effect early next year.
NextBio receives phase II SBIR grant to add new genomic and proteomic content
NextBio has announced the receipt of a Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH).
Lorcaserin Phase 3 trial data on type 2 diabetes to be presented at ADA 2011
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that lorcaserin data from the Phase 3 BLOOM-DM trial will be presented in poster sessions at the American Diabetes Association's (ADA) 71st Scientific Sessions in San Diego, California.
› Verified 3 days ago